paclitaxel has been researched along with Mixed Tumor, Mullerian in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 13 (65.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dasanu, CA; Farrell, S; Grover, M; Hwang, A; Iskandar, AS; Kerr, WT; Lerner, J; Ocampo, MM; Plaxe, SC | 1 |
| Chang, CW; Chen, CH; Cheng, CJ; Chiu, YH; Fu, HS; Liu, WM; Wang, ID; Wu, YC | 1 |
| Itamochi, H; Kanamori, Y; Kawaguchi, W; Kigawa, J; Oishi, T; Sato, S; Shimada, M; Terakawa, N | 1 |
| Atkinson, T; Horowitz, NS; Krag, KJ; Krasner, CN; Lee, H; Matulonis, UA; Penson, RT | 1 |
| Fukuda, H; Hatae, M; Iwasaka, T; Kamura, T; Kobayashi, H; Konishi, I; Nakanishi, T; Onda, T; Shibata, T; Yoshikawa, H | 1 |
| Duman, BB; Ercolak, V; Günaldi, M; Kara, IO | 1 |
| Daladimos, T; Kalinoglou, N; Karabelis, A; Kosmas, C; Moschovis, D; Mylonakis, N; Panagiotidi, E; Papachrysanthou, T; Politis, P; Tsakonas, G; Tsavaris, N; Vorgias, G | 1 |
| Choijamts, B; Emoto, M; Iwasaki, H; Jimi, S; Kondo, T; Kuroki, M; Matsumoto, T; Naganuma, Y | 1 |
| Ho, ES; Hsu, ST; Ke, YM; Lu, CH; Tsai, CP; Wang, RC | 1 |
| Cruickshank, ME; Delaney, E; Hutcheon, AW; McNally, OM; Parkin, DE; Petty, RD | 1 |
| Berkowitz, RS; Campos, SM; Duska, LR; Fuller, AF; Lee, H; Matulonis, UA; Penson, RT; Puchalski, TA; Seiden, MV; Supko, JG; Wilson, KS | 1 |
| Markman, M | 1 |
| Carneiro, F; Lima, J; Lopes, JM; Magro, F; Pereira, P; Saraiva, A; Sarmento, C; Tavarela-Veloso, F; Teixeira, A | 1 |
| Arano Bermejo, JI; Cabañas Navarro, L; Capote Armas, LF; González-Palacios Martínez, F; Reguero Callejas, ME; Ruiz Tovar, J | 1 |
| Campos, S; Duska, LR; Falke, R; Krasner, CN; Lee, H; Matulonis, UA; Penson, RT; Roche, M; Seiden, MV; Smith, LM | 1 |
| Ellard, S; Hoskins, PJ; Le, N; Lee, U; Martin, LA; Swenerton, KD; Tinker, AV | 1 |
| Eltabbakh, GH; Yadav, R | 1 |
| Comerci, JT; Edwards, RP; Kanbour-Shakir, A; Kelley, JL; Kunschner, AJ; Price, FV; Sit, AS | 1 |
| Allen, M; Gibbs, DD; Gore, ME; Johnston, SR; Pyle, L; Vaughan, M; Webb, A | 1 |
| Duska, LR; Eltabbakh, GH; Fuller, AF; Garrett, A; Oliva, E; Penson, R | 1 |
1 review(s) available for paclitaxel and Mixed Tumor, Mullerian
| Article | Year |
|---|---|
Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Female; Follow-Up Studies; Humans; Hysterectomy; Mixed Tumor, Mullerian; Neoplasm Staging; Omentum; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Palliative Care; Salpingectomy; Taxoids; Tomography, X-Ray Computed | 2011 |
5 trial(s) available for paclitaxel and Mixed Tumor, Mullerian
| Article | Year |
|---|---|
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Genital Neoplasms, Female; Humans; Mixed Tumor, Mullerian; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prospective Studies; Quality of Life | 2009 |
Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Fallopian Tube Neoplasms; Feasibility Studies; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Patient Compliance; Peritoneal Neoplasms | 2009 |
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Drug Interactions; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Paclitaxel; Uterine Neoplasms | 2003 |
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Topotecan | 2006 |
A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Fallopian Tube Neoplasms; Female; Humans; Infusions, Intravenous; Liposomes; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Paclitaxel; Treatment Outcome | 2002 |
14 other study(ies) available for paclitaxel and Mixed Tumor, Mullerian
| Article | Year |
|---|---|
Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms | 2020 |
Primary peritoneal carcinosarcoma: A report of two cases.
Topics: Abdominal Neoplasms; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Fatal Outcome; Female; Humans; Mixed Tumor, Mullerian; Paclitaxel; Peritoneal Neoplasms | 2019 |
Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Fallopian Tube Neoplasms; Female; Humans; Mixed Tumor, Mullerian; Ovariectomy; Paclitaxel | 2008 |
Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours.
Topics: Adnexal Diseases; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Mixed Tumor, Malignant; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Topics: AC133 Antigen; Animals; Antigens, CD; Antigens, Neoplasm; Carcinosarcoma; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Cell Separation; Cell Transformation, Neoplastic; Cisplatin; Drug Resistance, Neoplasm; Epithelial Cell Adhesion Molecule; Estrogen Receptor beta; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycoproteins; Homeodomain Proteins; Humans; Immunohistochemistry; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mixed Tumor, Mullerian; Nanog Homeobox Protein; Neoplastic Stem Cells; Octamer Transcription Factor-3; Paclitaxel; PAX2 Transcription Factor; Peptides; SOXB1 Transcription Factors; Uterine Neoplasms; Vimentin; Wnt4 Protein | 2011 |
Stage III malignant mixed Müllerian tumor of the fallopian tube: a case of 5-year survival after optimal debulking and adjuvant chemotherapy with paclitaxel plus carboplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Paclitaxel | 2012 |
Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Practice Guidelines as Topic; Prospective Studies; Radiotherapy Dosage; Survival Rate; Taxoids | 2003 |
Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Patient Selection; Quality of Life; Treatment Outcome; Uterine Neoplasms | 2004 |
Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colitis, Ulcerative; Colon; Constriction, Pathologic; Endoscopy, Gastrointestinal; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Paclitaxel; Peritoneal Neoplasms | 2005 |
Malignant mixed Mullerian tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Hysterectomy; Ifosfamide; Ilium; Middle Aged; Mixed Tumor, Mullerian; Neoplasms, Second Primary; Ovariectomy; Paclitaxel; Palliative Care; Pelvic Neoplasms; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Spinal Neoplasms; Uterine Neoplasms | 2006 |
Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms | 2008 |
Good response of malignant mixed mullerian tumor of the ovary to paclitaxel and cisplatin chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel | 1999 |
Chemotherapy for malignant mixed Müllerian tumors of the ovary.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome | 2000 |
Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Survival Rate | 2002 |